Year |
Citation |
Score |
2011 |
Goins WF, Krisky DM, Wechuck JB, Wolfe D, Huang S, Glorioso JC. Generation of replication-competent and -defective HSV vectors. Cold Spring Harbor Protocols. 2011: pdb.prot5615. PMID 21536761 DOI: 10.1101/pdb.prot5615 |
0.44 |
|
2009 |
Kato R, Wolfe D, Coyle CH, Wechuck JB, Tyagi P, Tsukamoto T, Nelson JB, Glorioso JC, Chancellor MB, Yoshimura N. Herpes simplex virus vector-mediated delivery of neurturin rescues erectile dysfunction of cavernous nerve injury. Gene Therapy. 16: 26-33. PMID 18668142 DOI: 10.1038/gt.2008.132 |
0.44 |
|
2008 |
Craft AM, Krisky DM, Wechuck JB, Lobenhofer EK, Jiang Y, Wolfe DP, Glorioso JC. Herpes simplex virus-mediated expression of Pax3 and MyoD in embryoid bodies results in lineage-Related alterations in gene expression profiles. Stem Cells (Dayton, Ohio). 26: 3119-29. PMID 18787207 DOI: 10.1634/stemcells.2008-0417 |
0.44 |
|
2008 |
Goins WF, Krisky DM, Wechuck JB, Huang S, Glorioso JC. Construction and production of recombinant herpes simplex virus vectors. Methods in Molecular Biology (Clifton, N.J.). 433: 97-113. PMID 18679619 DOI: 10.1007/978-1-59745-237-3_6 |
0.44 |
|
2007 |
Kato R, Wolfe D, Coyle CH, Huang S, Wechuck JB, Goins WF, Krisky DM, Tsukamoto T, Nelson JB, Glorioso JC, Chancellor MB, Yoshimura N. Herpes simplex virus vector-mediated delivery of glial cell line-derived neurotrophic factor rescues erectile dysfunction following cavernous nerve injury. Gene Therapy. 14: 1344-52. PMID 17611585 DOI: 10.1038/sj.gt.3302990 |
0.44 |
|
2006 |
Jiang C, Ataai M, Ozuer A, Krisky D, Wechuck J, Pornsuwan S, Pourarian F, Glorioso JC. Inactivation of herpes simplex type 1 gene vector on immobilized metal affinity chromatography: oxidative damage by hydroxyl free radicals and its prevention. Biotechnology and Bioengineering. 95: 48-57. PMID 16673413 DOI: 10.1002/bit.20943 |
0.44 |
|
2004 |
Jiang C, Wechuck JB, Goins WF, Krisky DM, Wolfe D, Ataai MM, Glorioso JC. Immobilized cobalt affinity chromatography provides a novel, efficient method for herpes simplex virus type 1 gene vector purification. Journal of Virology. 78: 8994-9006. PMID 15308696 DOI: 10.1128/JVI.78.17.8994-9006.2004 |
0.44 |
|
2004 |
Wolfe D, Wechuck JB, Krisky DM, Goff JP, Goins WF, Ozuer A, Epperly ME, Greenberger JS, Fink DJ, Glorioso JC. Delivery of herpes simplex virus-based vectors to stem cells. Methods in Molecular Biology (Clifton, N.J.). 246: 339-52. PMID 14970603 |
0.44 |
|
2002 |
Wechuck JB, Ozuer A, Goins WF, Wolfe D, Oligino T, Glorioso JC, Ataai MM. Effect of temperature, medium composition, and cell passage on production of herpes-based viral vectors. Biotechnology and Bioengineering. 79: 112-9. PMID 17590937 DOI: 10.1002/bit.10310 |
0.44 |
|
2002 |
Ozuer A, Wechuck JB, Russell B, Wolfe D, Goins WF, Glorioso JC, Ataai MM. Evaluation of infection parameters in the production of replication-defective HSV-1 viral vectors. Biotechnology Progress. 18: 476-82. PMID 12052062 DOI: 10.1021/bp010176k |
0.44 |
|
2002 |
Ozuer A, Wechuck JB, Goins WF, Wolfe D, Glorioso JC, Ataai MM. Effect of genetic background and culture conditions on the production of herpesvirus-based gene therapy vectors. Biotechnology and Bioengineering. 77: 685-92. PMID 11807764 DOI: 10.1002/bit.10162 |
0.44 |
|
2001 |
Burton EA, Wechuck JB, Wendell SK, Goins WF, Fink DJ, Glorioso JC. Multiple applications for replication-defective herpes simplex virus vectors. Stem Cells (Dayton, Ohio). 19: 358-77. PMID 11553845 DOI: 10.1634/stemcells.19-5-358 |
0.44 |
|
2000 |
Wechuck JB, Goins WF, Glorioso JC, Ataai MM. Effect of protease inhibitors on yield of HSV-1-based viral vectors. Biotechnology Progress. 16: 493-6. PMID 10835254 DOI: 10.1021/bp000016t |
0.44 |
|
Show low-probability matches. |